Small-cap CNS out­fit inks API deal for pre­clin­i­cal MEK in­hibitor

Mi­a­mi-based pen­ny stock play­er Pa­sithea Ther­a­peu­tics is team­ing with CD­MO WuXi STA to make the ac­tive phar­ma­ceu­ti­cal in­gre­di­ent for its lead pre­clin­i­cal drug — com­plet­ing one …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER